ArticleTargeted oncology2025

Weight-Based Pembrolizumab Dosing at 4 mg/kg Every 6 Weeks Leads to Exposures Below Approved Doses with Unestablished Efficacy: A Pharmacokinetic Model-Based Simulation Analysis.

Mallika Lala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.